Our PIPELINE Products
News & Media
| Board of Directors
Jonathan Symonds, CBE
Chairperson since May 2014
Has been Director of HSBC Holdings plc and Chairman of HSBC Bank plc since April 2014
Serves as an independent director and Chairman of the audit committee of Genomics England Limited, and is Chairman of Proteus Digital Health.
Was appointed Commander of the British Empire (CBE) for services to business and the pharmaceutical industry in January 2007
Was previously CFO of Novartis AG, partner and Managing Director of Goldman Sachs, CFO of AstraZeneca plc, and a partner of KPMG.
Has served on the board of directors of Diageo plc and Qinetiq plc
Received a BA in Business Finance from the University of Hertfordshire, where he also received an honorary doctorate.
Shumeet Banerji, PhD
Vice-Chairperson since May 2014
Is co-founder and partner of Condorcet, LP, a private investment and advisory firm
Was a founding Chief Executive Officer of the global management consulting firm Booz & Company from 2008 to 2012, and served as a senior partner from May 2012 to March 2013
Held multiple roles at consulting company Booz Allen Hamilton, including President of the worldwide commercial business, including Managing Director, Europe, and Managing Director, United Kingdom, and was elected every year for 10 years to the firm’s board of directors
Has been a director of the Hewlett-Packard Company since January 2011
Received his PhD from the Kellogg School of Management at Northwestern University
David R. Brennan
Member of Innocoll’s Board since May 2014
Has over 40 years of industry experience where he served as the CEO of AstraZeneca plc, and prior to that he served as President and CEO of AstraZeneca's North American subsidiary.
Currently serving as a Director on the boards of Alexion Pharmaceuticals, and Insmed Pharmaceuticals.
Served as: executive director of AstraZeneca plc, executive board member and Chairman of the Pharmaceutical Research and Manufacturers of America, member of the executive board of the European-Federation for Pharmaceutical Industries and Association, and President of the International Federation of Pharmaceutical Manufacturers and Associations.
Was a participant and member of the International Business Council of the World Economic Forum
Holds a BA in Business Administration from Gettysburg College, where he currently serves on
Member of advisory board, the predecessor to the supervisory board, since August 2013
Has over 30 years of experience in the pharmaceutical industry in pharmaceutical company analysis, investment banking, and healthcare private equity
Joined Hoare Govett in 1982, where he became Director of European Healthcare Research
Joined Merrill Lynch & Co. in 1995, where he became Head of European Pharmaceutical Research and Global Coordinator for Healthcare Research, and established a top-rated franchise
Formed Sudbrook Associates, a healthcare corporate advisory, in 2004, specializing in fundraising, corporate advice, and due diligence in the private healthcare sector
Sits on the boards of four other companies in the specialty pharmaceutical, drug development and diagnostic field
Received a MSc from the University of Aberdeen
Rolf D. Schmidt
Member of Innocoll's board in 1997, chairperson from 1997 – 2010
Was a co-founder of the medical bio-adhesives product company, Closure Medical Corporation, and led the company as Chairperson from its early development through its initial public offering in 1996 and until its acquisition by Johnson & Johnson in 2005
Co-founded Sharpoint, Inc., a leading developer and manufacturer of ophthalmic surgical needles and sutures prior to its acquisition by Alcon Labs, Inc. in 1986
Actively consults with and invests in early-stage healthcare technology companies
Member of Innocoll’s Board since December 2014
Has over 20 years of experience in the pharmaceutical, medical, and venture capital industries
Was Medical Director at Astellas Pharma and held investment roles at Sofinnova Ventures, Spirit Capital, Inventages Venture Capital, and Aberdeen Asset Managers (UK). He is currently CEO of London listed Amryt Pharma plc
Trained in general medicine at Trinity College Dublin, specializing in neurology
Member of the Royal College of Physicians in Ireland